Top News

• PDUFA VIII Commitment Letter Outlines Changes to Drug Review, Manufacturing Oversight
• Experts Warn of Edema Risk With Vykat XR as FDA Evaluates Risk
• FDA Seeks Injunction Against Steiner Biotechnology
• FDA Questions Zynlontas Benefit/Risk: Report
• Guidance on Risk-Based Approach to Drug Packaging Systems
• Replimune Approval Document Highlights Reviewer Objections
• FDA Meeting to Review Survival Data for Osteosarcoma Therapy
• FDA Warns Aurobindo Pharmas Eugia Unit